Fuller & Thaler Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
OAM
DM
B
AIM
NAMA
Fuller & Thaler Asset Management's CDNA Position: Q3 2025 in Review
Fuller & Thaler Asset Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 19,525 shares — an estimated $382K sold.
Fuller & Thaler Asset Management first reported a position in CDNA in Q3 2024 and held it in 4 quarters. The position peaked at $715K in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.
- Fuller & Thaler Asset Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
- Fuller & Thaler Asset Management sold 19,525 CareDx shares in Q3 2025, an estimated $382K.
- Fuller & Thaler Asset Management first reported a position in CareDx in Q3 2024 and held it in 4 quarters.
- Fuller & Thaler Asset Management's CareDx position peaked at $715K in Q3 2024.
- 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.
Based on Fuller & Thaler Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.